Literature DB >> 14532997

Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma.

Katsuya Shiraki1, Kazushi Sugimoto, Yutaka Yamanaka, Yumi Yamaguchi, Yukiko Saitou, Keiichi Ito, Norihiko Yamamoto, Takenari Yamanaka, Katsuhiko Fujikawa, Kazumoto Murata, Takeshi Nakano.   

Abstract

The X-linked inhibitor of apoptosis (XIAP) is a member of a novel family of inhibitors of apoptosis. Since suppression of apoptosis is fundamentally important for carcinogenesis and tumor growth, we investigated the expression and function of XIAP in human hepatocellular carcinomas (HCCs). XIAP was expressed constitutively in HCC cell lines. Fourteen out of 20 (70%) HCC tissues demonstrated moderate or strong cytoplasmic staining for XIAP, whereas non-tumor parts showed negative or weak staining for XIAP by immunohistochemistry. In addition, XIAP expression was inversely correlated with apoptosis, but not with proliferation in HCC tissues. These results indicated that XIAP is a principal inhibitor of apoptosis overexpressed in human HCCs and that XIAP may be a potential target for gene therapy of human HCCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532997

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Authors:  Collins A Karikari; Indrajit Roy; Eric Tryggestad; Georg Feldmann; Clemencia Pinilla; Kate Welsh; John C Reed; Elwood P Armour; John Wong; Joseph Herman; Dinesh Rakheja; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2007-03-05       Impact factor: 6.261

2.  Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence.

Authors:  Ying-Hong Shi; Wen-Xing Ding; Jian Zhou; Jun-Yi He; Yang Xu; Andrea A Gambotto; Hannah Rabinowich; Jia Fan; Xiao-Ming Yin
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

3.  Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.

Authors:  Saskia A G M Cillessen; John C Reed; Kate Welsh; Clemencia Pinilla; Richard Houghten; Erik Hooijberg; José Deurhof; Kitty C M Castricum; Pim Kortman; Corine J Hess; Gert J Ossenkoppele; Chris J L M Meijer; Joost J Oudejans
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

Review 4.  Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

Authors:  Natale D'Alessandro; Paola Poma; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

5.  Clinical significance of autophagic protein LC3 levels and its correlation with XIAP expression in hepatocellular carcinoma.

Authors:  Wen-Yong Wu; Hyunchul Kim; Chang-Le Zhang; Xiang-Ling Meng; Zheng-Sheng Wu
Journal:  Med Oncol       Date:  2014-07-09       Impact factor: 3.064

6.  Monoglyceride lipase mediates tumor-suppressive effects by promoting degradation of X-linked inhibitor of apoptosis protein.

Authors:  Renyan Liu; Xin Wang; Christopher Curtiss; M Saeed Sheikh; Ying Huang
Journal:  Cell Death Differ       Date:  2020-05-06       Impact factor: 15.828

7.  Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.

Authors:  Konstantin Golovine; Peter Makhov; Robert G Uzzo; Alexander Kutikov; David J Kaplan; Eric Fox; Vladimir M Kolenko
Journal:  Mol Cancer       Date:  2010-07-09       Impact factor: 27.401

8.  Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.

Authors:  Bart Spee; Martijn D B Jonkers; Brigitte Arends; Gerard R Rutteman; Jan Rothuizen; Louis C Penning
Journal:  Mol Cancer       Date:  2006-09-05       Impact factor: 27.401

9.  Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

Authors:  Claudia Augello; Luca Caruso; Marco Maggioni; Matteo Donadon; Marco Montorsi; Roberto Santambrogio; Guido Torzilli; Valentina Vaira; Caterina Pellegrini; Massimo Roncalli; Guido Coggi; Silvano Bosari
Journal:  BMC Cancer       Date:  2009-04-27       Impact factor: 4.430

10.  Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Chao-Wen Xiao; Tian-Geng You; Ya-Xin Zheng; Wei Gao; Zhu-Qing Zhou; Jun Chen; Xin-Bo Xue; Jia Fan; Hui Zhang
Journal:  Mol Cancer       Date:  2012-05-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.